MedTrace Logo

Remote Diagnosis and Management of Obstructive Sleep Apnea

NCT03007745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 435

Last updated 2025-05-20

Study results available
· View outcomes & findings →

Summary

Although obstructive sleep apnea, a breathing disorder during sleep, is prevalent and recognized as a major public health concern, most Veterans with this disorder are undiagnosed and therefore untreated. Access to sleep laboratories for testing is limited particularly for those Veterans living in rural areas and Veterans with disabilities that prevent travel to a sleep center. The goal of this study is to compare a web-based telehealth management strategy to in-person management. The telehealth pathway will enable Veterans to be diagnosed and treated without visiting a sleep center. The investigators believe that telehealth management will increase Veterans' access to this specialized care at a cost that is less than in-person delivery but with similar improvements in daytime function.

Conditions

  • Sleep Apnea - Obstructive
  • Cost Effectiveness
  • Telemedicine

Interventions

DEVICE

autoadjusting continuous positive airway pressure

Participants in both arms who are diagnosed with obstructive sleep apnea will be treated with autoadjusting continuous positive airway pressure

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Samuel T. Kuna, MD · Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-24
Primary Completion
2021-01-31
Completion
2021-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03007745 on ClinicalTrials.gov